Clinicopathological variants | BCG group (n = 46) | EPI group (n = 12) | Total (n = 58) | P-value |
---|---|---|---|---|
Gender | 0.432 | |||
Male | 35 | 11 | 46 | |
Female | 11 | 1 | 12 | |
Preoperative age (years) | 0.336 | |||
≤ 60 | 18 | 7 | 25 | |
60–70 | 19 | 4 | 23 | |
> 70 | 9 | 1 | 10 | |
Smoking history | 0.331 | |||
No | 25 | 4 | 29 | |
Yes | 21 | 8 | 29 | |
Prior recurrence rate | 0.233 | |||
Primary | 27 | 5 | 32 | |
Recurrent, ≤ 1 rec/year | 11 | 2 | 13 | |
Recurrent, > 1 rec/year | 8 | 5 | 13 | |
T category | 0.012 | |||
Ta | 29 | 12 | 41 | |
T1 | 17 | 0 | 17 | |
Grade | 0.331 | |||
Low grade | 21 | 8 | 29 | |
High grade | 25 | 4 | 29 | |
Tumor size (cm) | 0.759 | |||
< 3 | 26 | 8 | 34 | |
≥ 3 | 20 | 4 | 24 | |
No. tumors | 0.891 | |||
≤ 3 | 34 | 8 | 42 | |
> 3 | 12 | 4 | 16 | |
Risk stage | 0.291 | |||
Intermediate risk | 19 | 5 | 26 | |
High risk | 27 | 5 | 32 | |
EORTC risk tables | 0.956 | |||
1–4 | 17 | 3 | 20 | |
5–9 | 24 | 9 | 33 | |
10–17 | 5 | 0 | 5 | |
CUETO scoring model | 0. 866 | |||
0–4 | 13 | 3 | 16 | |
5–6 | 16 | 5 | 21 | |
7–9 | 15 | 4 | 19 | |
10–16 | 2 | 0 | 2 |